Can I read Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions on EtoBox?

Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions by Charles Awortwe; Ingolf Cascorbi is a Medicine article available to read on EtoBox.

What is Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions about?

Drug-drug interactions (DDI) potentially occurring between medications used in the course of COVID-19 infection and medications prescribed for the management of underlying comorbidities may cause adverse drug reactions (ADRs) contributing to worsening of the clinical outcome in affected patients. First, we conducted a meta-analysis to determine comorbidities observed in the course of COVID-19 disease associated with an increased risk of worsened clinical outcome from 24 published studies. In addition, the potential risk of DDI between medications used in the course of COVID-19 treatment in these studies and those for the management of observed comorbidities was evaluated for possible worsening of the clinical outcome. Our meta-analysis revealed an implication cardiometabolic syndrome (e.g. cardiovascular disease, cerebrovascular disease, hypertension, and diabetes), chronic kidney disease and chronic obstructive pulmonary disease as main co-morbidities associated with worsen the clinical outcomes including mortality (risk difference RD 0.12, 95 %-CI 0.05-0.19, p = 0.001), admission to ICU (RD 0.10, 95 %-CI 0.04-0.16, p = 0.001) and severe infection (RD 0.05, 95 %-CI 0.01-0.09, p =

Who reads Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions?

Author

Charles Awortwe; Ingolf Cascorbi

Publisher

Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1043-6618)

Published

2020

Language

EN

Field

Medicine (Life Sciences)